SOURCE: MusclePharm Corp.
DENVER, CO--(Marketwire - Mar 21, 2013) - MusclePharm Corporation (OTCQB: MSLP), a nutritional supplement company focused on active lifestyles, is proud to announce it has signed a multi-year endorsement deal with the NFL San Francisco 49ers Super Bowl quarterback Colin Kaepernick. As part of the relationship, Kaepernick will represent MusclePharm in a series of advertisements, radio and television appearances, and social media outlets.
Kaepernick is considered one of the fastest raising stars in the NFL. Drafted in 2011 in the second round by the San Francisco 49ers, Kaepernick became the team's full-time starter in the middle of the 2012 season leading the 49ers into the NFL playoffs. In his first career postseason start, he put forth an electrifying performance against the Green Bay Packers setting an NFL single-game record for most rushing yards (181) by a quarterback. After beating the Atlanta Falcons in the NFC Championship, he led the 49ers to their first Super Bowl appearance since 1994 against the Baltimore Ravens.
Commenting on the announcement, Kaepernick stated, "I added MusclePharm supplements to my routine at the beginning of my rookie season in the NFL. MP covers all my needs when it comes to energy, recovery and increased productivity both on and off the field. I am honored to become part of the MusclePharm team and look forward to representing their highly regarded brand."
Commenting on the announcement, MusclePharm Founder & CEO, Brad Pyatt, stated, "Kaepernick's reputation as a workout fanatic coupled with his amazing physique makes him an ideal fit with the MusclePharm brand. He is both an articulate and charismatic young man with a work ethic and competitive drive that complement his dynamic athleticism. We are thrilled to have him represent MusclePharm."
ABOUT MUSCLEPHARM CORPORATION
MusclePharm is a healthy lifestyle company that develops and manufactures nutritional supplements which address active lifestyles, including muscle building, weight loss and maintaining general fitness through a daily nutritional supplement regimen. The products are formulated through a six-stage research process using the expertise of leading nutritional scientists. MusclePharm's products are sold to consumers in more than 110 countries and available in over 10,500 U.S. retail outlets, including Dick's Sporting Goods, GNC, Vitamin Shoppe and Vitamin World. MusclePharm products also are sold through more than 100 online channels globally, including bodybuilding.com, amazon.com and vitacost.com. MusclePharm also owns FitMiss™, a branded line of fitness supplements which is designed, dosed and formulated specifically for women with active lifestyles. For more information, please visit http://musclepharm.com/.
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K/A for the fiscal year ended December 31, 2011, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.